These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4461132)

  • 1. [Immunological study of chronic obstructive pulmonary diseases].
    Oshima S
    Bull Chest Dis Res Inst Kyoto Univ; 1974 Dec; 8(1):34-8. PubMed ID: 4461132
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in immunoglobulins in the sputum and serum after the use of secretolytics in patients with chronic obstructive pulmonary disease].
    Prazić B; Acketa M; Obradović-Andelić S; Volf-Pavlović E
    Plucne Bolesti; 1985; 37(3-4):178-82. PubMed ID: 3836422
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differences in the values of immunoglobulins and alpha 1-antitrypsin and the justification for their measurement in chronic obstructive lung diseases].
    Dizdarević Z
    Plucne Bolesti; 1985; 37(1-2):37-42. PubMed ID: 3877944
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-1-antitrypsin phenotypes, serum immunoglobulins and circulating bacterial antibodies in Nigerians with chronic obstructive pulmonary disease.
    Olusi SO; Adeyemo AO
    East Afr Med J; 1983 Jul; 60(7):506-11. PubMed ID: 6605847
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of IgE as compared with other immunoglobulins in bronchial asthma and chronic obstructive bronchopneumopathy].
    Georgescu I; Burnea D; Morgenstern H; Algeorge G; Duţu S; Pătru V; Ivan I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):83-90. PubMed ID: 6312540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of Yiqi-Huoxue injections on certain gas exchange functions and serum immunoglobulins in patients with chronic obstructive pulmonary diseases].
    Lin YH; Huang XC; Zhou ZA; Wu QY; He XM; Fang MY; Nie LC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():12-16. PubMed ID: 6459871
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease.
    Falk GA; Okinaka AJ; Siskind GW
    Am Rev Respir Dis; 1972 Jan; 105(1):14-21. PubMed ID: 4621423
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological and nonspecific reactivity in patients with infiltrative pulmonary tuberculosis associated with chronic nonspecific lung diseases].
    Morozova TI; Khudzik LB; Rebrov AP
    Probl Tuberk; 1995; (4):14-7. PubMed ID: 7567859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenetic aspects of the determinism and evolution of chronic obstructive bronchopneumopathy (COBP)].
    Anastasatu C; Morgenstern H; Burnea D; Cristea M; Algeorge G; Păunescu E; Bogdănescu V; Petre A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):219-27. PubMed ID: 232303
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoglobulin IgE concentrations in an adult clinical material with chronic obstructive pulmonary disease.
    Dahlström G; Johansson G; Kiviloog J
    Scand J Respir Dis; 1973; 54(2):73-7. PubMed ID: 4707480
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary study of the deficiency of cellular immunity in patients with chronic obstructive pulmonary disease].
    Hu BX
    Zhonghua Yi Xue Za Zhi; 1985 Dec; 65(12):736-8. PubMed ID: 3938958
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease and secretory IgA.
    Zinneman HH; Niewoehner DE; Goodsell MG
    Minn Med; 1980 Apr; 63(4):247-9. PubMed ID: 6966737
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors related to serum and secretory immunoglobulin concentrations in patients with chronic obstructive pulmonary disease.
    Orfanakis MG; Smith CB; Klauber MR; Smith H; Krall J; Renzetti AD
    Am Rev Respir Dis; 1973 May; 107(5):728-34. PubMed ID: 4695624
    [No Abstract]   [Full Text] [Related]  

  • 14. [The relevance of serum-complement factors in chronic obstructive pulmonary disease (author's transl)].
    Lanzer G; Borkenstein J
    Acta Med Austriaca; 1981; 8(3):93-8. PubMed ID: 6911988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of disorders of lipid peroxidation homeostasis and immunologic indicators in patients with chronic respiratory diseases working in chemical industry].
    Abramovskaia AK; Chernous VI; Gurevich GL; Kamyshnikov VS
    Med Tr Prom Ekol; 1993; (2):9-12. PubMed ID: 8061975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tobacco mosaic virus and chronic pulmonary diseases].
    Frappier-Davignon L; Chagnon A; Hamilton R; Lamoureux G
    Union Med Can; 1987 Jan; 116(1):49-52. PubMed ID: 3564178
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of an artificial microclimate chamber in the treatment of patients with chronic obstructive lung diseases].
    Chernenkov RA; Chernenkova EA; Zhukov GV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (4):19-21. PubMed ID: 9424823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The characteristics of the clinical course and treatment of chronic obstructive lung diseases against a background of lymphoproliferative diseases].
    Provotorov VM; Kazabtsov AIu
    Ter Arkh; 1997; 69(3):19-23. PubMed ID: 9229820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of regional lung function in the early detection of chronic obstructive pulmonary disease.
    McKusick KA; Wagner HN; Soin JS; Benjamin JJ; Cooper M; Ball WC
    Scand J Respir Dis Suppl; 1974; 85():51-63. PubMed ID: 4534922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The macrophagic activity of patients affected by pneumonia or chronic obstructive pulmonary disease.
    Ferrara F; D'Adda D; Falchi M; Dall'Asta L
    Int J Tissue React; 1996; 18(4-6):109-14. PubMed ID: 9195246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.